| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 09/28/2004 | US6797820 Succinate compounds, compositions and methods of use and preparation |
| 09/28/2004 | US6797720 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient |
| 09/28/2004 | US6797709 Sexual disorders |
| 09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
| 09/23/2004 | WO2004081006A1 Weak base salts |
| 09/23/2004 | WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004081001A1 Novel 2-pyridinecarboxamide derivatives |
| 09/23/2004 | WO2004080998A1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080977A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | WO2004080972A1 Pirazole modulators of atp-binding cassette transporters |
| 09/23/2004 | WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs |
| 09/23/2004 | WO2004080964A1 Indole derivatives useful for the treatment of diseases |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080422A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 09/23/2004 | WO2004056785A3 Uracils having a herbicidal activity |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004030637A3 Treatment of obesity and other disorders associated with excessive food intake |
| 09/23/2004 | WO2004010944A3 Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186293 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle |
| 09/23/2004 | US20040186290 transferase enzyme modulators such as 2-(6-Chloropyridin-3-yl)-3-cyclopentyl-N-thiazol-2-ylpropionamide, used for prophylaxis of hyperglycemia and diabetes |
| 09/23/2004 | US20040186168 Such as spiroadamantane on one side and 4-substituted spiro-cyclohexyl on other side; structurally simple, nontoxic, easy synthesis, potent parasiticides |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186142 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186132 Steroid receptor modulator compounds and methods |
| 09/23/2004 | US20040186119 glycogen synthase kinase (GSK-3) inhibitors; for treatment of diabetes and alzheimer's disease |
| 09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 09/23/2004 | US20040186115 for treatment of proliferative, cardiac, neurodegenerative, and autoimmune disorders |
| 09/23/2004 | US20040186114 Cytokine inhibitors |
| 09/23/2004 | US20040186111 Therapeutic agents useful for treating pain |
| 09/23/2004 | US20040186109 piperazine derivatives, e.g., (2R)-1-(2-methylbenzothiazol-5-yloxy)-3-[4-({5-[4-(trifluoromethyl)phenyl](4,5-dihydroisoxazol-3-yl)}methyl)piperazinyl]propan-2-ol; treating diabetes, arrhythmia, intermittent claudication, angina, congestive heart disease, and myocardial infarction |
| 09/23/2004 | US20040186108 such as N-{2-[2-(4-1,2-Benzisothiazol-3-yl-piperazin-1-yl)-ethyl]-phenyl}-2-(2,5-dimethoxy-phenyl)-acetamide; antagonists of dopamine D2 receptors and of serotonin 2A (5HT2a) receptors; for treatment of depression and dementia/schizophrenia |
| 09/23/2004 | US20040186101 such as 6-(3-Chlorophenyl)-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one; hormone replacement therapy |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186097 such as N-phenyl-3-[[4-(phenylmethyl)-1-piperidinyl]methyl]-1-piperidinecarboxamide for prevention of asthma and allergies |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
| 09/23/2004 | US20040186021 Substituted benzo-nitro-heterocycles |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/23/2004 | DE10310278A1 New N-(benzazinyl)-(hetero)aralkylamine derivatives, are inhibitors of factor Xa and/or related serine proteases, useful e.g. as antithrombotic agents and intermediates |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | CA2518513A1 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | CA2517569A1 Indole derivatives useful for the treatment of diseases |
| 09/23/2004 | CA2515289A1 Weak base salts |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1458710A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
| 09/22/2004 | EP1458697A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458684A2 Therapeutic heterocycles |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458393A1 Substituted diketopiperazines as oxytocin antagonists |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458383A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2004 | EP1458382A1 Amide derivatives as gk activators |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1283205B1 Naphthol derivatives |
| 09/22/2004 | EP1268475B1 Novel benzosultam oxazolidinone antibacterial agents |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP0706524B1 Processes and intermediates for the preparation of 5- 2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 09/22/2004 | CN1167702C Polymroph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
| 09/21/2004 | US6794506 Treatment of inflammatory diseases, such as asthma, alzheimer's disease, atherosclerosis, aids dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794393 Tyrosine kinase inhibitors |
| 09/21/2004 | US6794383 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 09/21/2004 | CA2277947C Pyrrolidine derivatives having phospholipase a2 inhibitory activity |
| 09/21/2004 | CA2033143C Alkyl esters of 5-heterocyclic-pyridine-2,3-dicarboxylate acids, 5-heterocyclic 2-(2-imidazoline-2-yl)pyridines, useful as herbicidal agents and methods for the preparation thereof |
| 09/16/2004 | WO2004079732A1 Optical recording materials having high storage density |
| 09/16/2004 | WO2004078754A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 09/16/2004 | WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/16/2004 | WO2004078749A1 Heterocyclic urea derivatives for the treatment of pain |
| 09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078745A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |